Hermetica Superfood Encyclopedia
The Short Answer
Umckaloabo (Pelargonium sidoides) is a South African geranium extract containing gallic acid, catechin, and proanthocyanidins that combat respiratory infections. Its active compounds inhibit bacterial adhesion to mucous membranes while stimulating interferon production and macrophage activity.
CategoryAfrican Traditional Medicine
GroupAfrican
Evidence LevelStrong
Primary KeywordUmckaloabo benefits
Synergy Pairings5
Pelargonium sidoides (Umckaloabo) — botanical close-up
Health Benefits
Boosts respiratory health by reducing bronchial inflammation, easing breathing
- Enhances immune response by increasing antibody production, fighting infections. - Supports sinus health by reducing mucus production, clearing nasal passages. - Provides antioxidant protection by neutralizing free radicals, supporting cellular health. - Improves mood by modulating neurotransmitter levels, enhancing mental well-being. - Aids in managing colds by shortening duration, reducing symptom severity. - Supports cardiovascular health by improving blood flow, reducing heart strain.
Origin & History
Natural habitat
Pelargonium sidoides, commonly known as Umckaloabo, is a plant native to Southern Africa. It is traditionally harvested for its roots, which are used in various forms, such as liquid extracts and capsules.
“Pelargonium sidoides has been used in African traditional medicine for centuries to treat respiratory ailments. It is valued for its potential to alleviate symptoms and promote recovery.”Traditional Medicine
Scientific Research
Some studies, including randomized controlled trials, suggest Pelargonium sidoides may be effective in reducing symptoms and duration of respiratory infections, such as bronchitis and the common cold.
Preparation & Dosage
Traditional preparation
Typical dosage is 30-60 drops of extract three times daily. Consult a healthcare provider before use.
Nutritional Profile
Pelargonium sidoides is not consumed as a food source but rather as a medicinal preparation (root extract), so traditional macronutrient profiling is not applicable. The root is rich in distinct bioactive compounds: **Polyphenols & Coumarins** — contains umckalin (7-hydroxy-5,6-dimethoxycoumarin, ~0.01–0.05% dry weight), scopoletin (~0.005–0.02%), and 6,8-dihydroxy-5,7-dimethoxycoumarin; these are the primary immunomodulatory agents. **Proanthocyanidins (condensed tannins)** — prodelphinidins and procyanidins constitute approximately 5–12% of the dry root extract (EPs 7630 standardized extract), responsible for significant antiviral and antibacterial activity. **Gallic acid and gallic acid derivatives** — including gallic acid methyl ester (~0.1–0.5%), contributing to antioxidant capacity. **Simple phenolic acids** — caffeic acid, p-coumaric acid, and their glycosides in trace amounts. **Minerals** — calcium (~200–400 mg/100g dry root), potassium (~300–600 mg/100g), magnesium (~80–150 mg/100g), iron (~5–15 mg/100g), and zinc (~2–5 mg/100g); values vary with soil conditions. **Carbohydrates** — mucilaginous polysaccharides (~3–8% dry weight) with potential prebiotic activity. **Tannin content** — total tannins range from 8–15% in dried root material, which can reduce bioavailability of co-consumed minerals and proteins. **Vitamins** — negligible; not a meaningful source of any vitamin. **Protein & fat** — minimal; root contains roughly 3–6% crude protein and <1% lipids. **Fiber** — crude fiber approximately 15–25% of dry root material. **Bioavailability notes** — The standardized hydroethanolic extract (EPs 7630, 11% ethanol w/w) significantly enhances the solubility and absorption of coumarins and proanthocyanidins compared to crude root powder. Umckalin and related coumarins are moderately bioavailable orally; prodelphinidins have lower systemic bioavailability but exert local effects in the gastrointestinal and respiratory mucosa. High tannin content may bind dietary iron and proteins if taken with meals, so administration on an empty stomach is generally recommended for optimal bioactive absorption.
How It Works
Mechanism of Action
Umckaloabo's gallic acid and proanthocyanidins prevent bacterial and viral adhesion to respiratory epithelial cells while disrupting biofilm formation. The extract stimulates interferon-γ production, enhances natural killer cell activity, and increases secretory IgA in respiratory mucosa. Catechin compounds provide additional antioxidant protection by scavenging reactive oxygen species.
Clinical Evidence
Multiple randomized controlled trials involving over 2,000 participants demonstrate umckaloabo's efficacy for acute bronchitis and upper respiratory infections. Studies show 40-50% reduction in bronchitis severity scores and 2-3 day shorter symptom duration compared to placebo. Meta-analyses confirm significant benefits for acute rhinosinusitis and common cold symptoms. Most trials used standardized EPs 7630 extract at 30-60mg daily for 7-10 days.
Safety & Interactions
Umckaloabo is generally well-tolerated with mild gastrointestinal upset reported in 5-8% of users. Rare cases of liver enzyme elevation have been documented, requiring monitoring in individuals with hepatic conditions. The extract may enhance warfarin activity due to coumarin content, necessitating INR monitoring. Pregnancy and breastfeeding safety data are insufficient, warranting avoidance during these periods.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Pelargonium sidoidesSouth African GeraniumAfrican PotatoKalwerbossieRabassamEPs 7630Umckamin
Frequently Asked Questions
How long does umckaloabo take to work for bronchitis?
Clinical studies show umckaloabo begins reducing bronchitis symptoms within 2-3 days, with maximum benefits typically achieved after 5-7 days of treatment. Most trials used 7-10 day treatment courses with the standardized EPs 7630 extract.
What is the active ingredient in umckaloabo?
Umckaloabo's primary active compounds include gallic acid, catechin, epicatechin, and oligomeric proanthocyanidins. The standardized EPs 7630 extract contains 11-15% total polyphenols, with gallic acid comprising approximately 0.2-1.0% of the extract.
Can umckaloabo be taken with antibiotics?
Umckaloabo can generally be taken alongside antibiotics for respiratory infections, potentially enhancing treatment outcomes. However, consult healthcare providers before combining treatments, especially with warfarin or other anticoagulants due to potential interaction risks.
What is the recommended umckaloabo dosage for adults?
Clinical trials typically use 30mg of standardized EPs 7630 extract three times daily (90mg total) for acute bronchitis. For general respiratory support, 20-30mg twice daily is commonly recommended, taken 30 minutes before meals.
Does umckaloabo work for viral infections like colds?
Yes, randomized controlled trials show umckaloabo reduces common cold symptom severity by 25-35% and shortens duration by 1-2 days. Its antiviral activity stems from preventing viral adhesion to respiratory cells and enhancing interferon production.
Is umckaloabo safe for children, and what is the appropriate dosage?
Umckaloabo has been studied in children and is generally considered safe when dosed appropriately by age and weight. Typical pediatric dosing is lower than adult doses, usually ranging from 1-3 mL of liquid extract daily depending on age, and should be determined by a healthcare provider. Clinical studies have shown benefits for respiratory infections in children without significant adverse effects at recommended doses.
What does clinical research show about umckaloabo's effectiveness compared to standard cough medicines?
Several randomized controlled trials have demonstrated that umckaloabo is effective for acute bronchitis, with some studies showing comparable or superior outcomes to standard cough suppressants and expectorants. Research indicates it may reduce symptom duration and severity by 2-3 days on average, though effects are more pronounced when started early in infection. The evidence base is moderate to good, with most studies conducted in Germany and South Africa where it is widely used.
Can umckaloabo be taken long-term for chronic respiratory conditions, or is it only for acute use?
Umckaloabo is primarily studied and used for acute respiratory infections like bronchitis and is typically recommended for short-term use of 1-3 weeks. While some practitioners use it preventatively during cold and flu season, long-term continuous use has not been extensively studied for safety or efficacy. Anyone considering extended use should consult a healthcare provider to determine appropriateness for their specific condition.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
